Intra-Articular Injection of Ketorolac for Post-Arthroscopic Pain Control

Comparison of Intra-Articular Injection of Ketorolac versus Placebo for Post-Arthroscopic Pain Control in Patients with Knee Ligaments and Menisci injuries

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015040721640N1

Enrollment

Registered

2015-04-27

Start date

2015-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain. Tear of meniscus, Sprain and strain involving (anterior)(posterior) cruciate ligament of knee

Interventions

Intervention 1: Control group: Intra-Articular Injection of Saline. Intervention 2: Intervention group: Intra-Articular Injection of Ketorolac.

Placebo

Prevention

Control group: Intra-Articular Injection of Saline

Intervention group: Intra-Articular Injection of Ketorolac

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient agreement; No history of cardiac and renal diseases; No history of lower limb fractures; No congenital disorders of extremities; No addiction to opioid. Exclusion criteria: History of regular analgesic and anti-inflammatory drugs; Neuropathies such as diabetes mellitus; Pregnancy; Patient with Coagulopathy; History of Gastro-Intestinal bleeding; History of Ketorolac-related complication or sensitivity

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Knee Pain. Timepoint: 24-hours after surgery. Method of measurement: Visual analogue scale.	—

Secondary

Measure	Time frame
Sleep disorder. Timepoint: Night after surgery. Method of measurement: Subjective.;Opioid requirement. Timepoint: 24-hours after surgery. Method of measurement: Doses used.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Mokhtari

Tabriz University of Medical Sciences

abolfazlmokhtari@yahoo.com+98 41 3389 3765

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026